Related Experiment Video
Updated: Apr 24, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
20.2K
Schizophrenia therapy options increasing.
P & T : a Peer-Reviewed Journal for Formulary Management
|September 12, 2014
Summary
New schizophrenia medications are emerging, offering hope for millions. The global market for these treatments is projected to grow significantly, indicating advancements in patient care and therapy effectiveness.
Area of Science:
- Neuroscience and Pharmacology
- Psychiatric Disorders
- Pharmaceutical Market Analysis
Background:
- Schizophrenia affects approximately 2.5 million patients worldwide.
- Current schizophrenia therapies generated $5.2 billion in global sales in 2012.
- The market for schizophrenia treatments is experiencing substantial growth.
Purpose of the Study:
- To highlight the potential of novel pharmacological interventions for schizophrenia.
- To project the future market growth for schizophrenia therapeutics.
- To underscore the evolving landscape of mental health treatment.
Main Methods:
- Analysis of current market data for schizophrenia medications.
- Projection of future market trends based on existing sales figures.
- Review of emerging therapeutic pipelines for schizophrenia.
Main Results:
- The global market for schizophrenia therapies is expected to increase from $5.2 billion in 2012 to $7.9 billion by 2022.
- This growth indicates a rising demand for more effective schizophrenia treatments.
- Emerging medications are anticipated to drive market expansion.
Conclusions:
- Significant advancements in schizophrenia treatment are on the horizon.
- The expanding market signifies increasing investment and innovation in psychiatric pharmacotherapy.
- Patients with schizophrenia can anticipate more effective therapeutic options in the near future.
More Related Videos
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
693
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
693
01:28Drug Therapy
442
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
442
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
01:29Psychological and Sociocultural Causes of Schizophrenia
956
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
956
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
1.2K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.2K